Latest Australian Government News

Morella Corporation has made significant progress in lithium and rubidium exploration across its Western Australian projects, while securing fresh funding through a recent share placement to support ongoing drilling and resource definition.

Tivan Limited reported significant progress in Q1 2025, including advancing a binding joint venture with Sumitomo Corporation for its Speewah Fluorite Project and securing seven exploration licenses for its Turiscai copper-gold project in Timor-Leste.

Vitrafy Life Sciences reported strong Q3 FY2025 progress, including a successful US Army blood platelet study, a $4.8 million government grant, and strategic US market expansion.

Brockman Mining Limited reports steady progress on its Marillana and Ophthalmia iron ore projects through joint ventures, infrastructure planning, and social consultations, while maintaining a stable financial position.

Krakatoa Resources has revealed promising extensions of antimony-gold mineralisation at its Zopkhito Project in Georgia, supported by recent geophysical modelling, while securing a drilling grant for its Mt Clere Project in Western Australia.

National Australia Bank’s first quarter update reveals a modest 2% dip in cash earnings despite a 3% revenue increase, as credit impairment charges and expenses rise. The bank’s refreshed strategy and strong capital position set the stage for cautious optimism.

Iluka Resources reported a solid FY 2024 with $1.13 billion in mineral sands revenue and a net profit of $231 million, while advancing key projects like Balranald and Eneabba refinery.

Iluka Resources posted a solid 2024 performance with stable market conditions and sound margins despite inflationary pressures, while progressing key projects like Balranald and Eneabba.

Iluka Resources reported a 32% drop in net profit after tax to $231 million for 2024, while securing critical funding for its Eneabba rare earths refinery and progressing the Balranald mine development.

Fletcher Building reported a challenging HY25 with a 7% revenue decline and a net loss of NZ$134 million, while executing a $700 million equity raise to strengthen its balance sheet and advancing significant cost reduction initiatives.

Zelira Therapeutics has received a $1.15 million cash refund from the Australian Government’s R&D Tax Incentive Scheme, bolstering its working capital to advance clinical development and business operations.

Lincoln Minerals is accelerating development across its diversified portfolio of critical minerals projects in South Australia's Gawler Craton, targeting copper, uranium, graphite, and high-purity iron to meet global electrification and decarbonization demands.